Terms: = Thyroid cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Prognosis
2 results:
1. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
[TBL] [Abstract] [Full Text] [Related]
2. Metastatic differentiated thyroid cancer: worst prognosis in patients with metachronous metastases.
González-Clavijo AM; Cuellar AA; Triana-Urrego J; Barrero JA; Fierro-Maya LF
Endocrine; 2023 Jul; 81(1):90-97. PubMed ID: 37171525
[TBL] [Abstract] [Full Text] [Related]
